control group:rhG-CSF
Sponsors
The Second Xiangya Hospital of Central South University; China Pharmaceutical University, Affiliated Cancer Hospital of Zhengzhou University, Cancer Hospital of Henan Province
Conditions
Cervical cancerself-financing
Phase 4
A multi-center post-marketing reevaluation and economic study of PEG-rhG-CSF in prevention of neutropenia after chemotherapy for malignant lymphoma
Active, not recruitingChiCTR1800017621
Start: 2018-08-06Updated: 2018-08-20
Prophylactic application of PEG-rhG-CSF during chemoradiotherapy for cervical cancer
Active, not recruitingChiCTR1900026309
Start: 2019-10-01Updated: 2019-09-30